Paul Abato, Ph.D | Medicinal Chemist Consultant

Pharmaceutical Expert Witness

Dr. Paul Abato

Independent Pharmaceutical Expert Witness

Independent Pharmaceutical Expert Witness, Dr. Abato expertise includes drug research, formulation, drug development, efficacy, pharmacokinetics, dosing routs, and pre-clinical testing.

Dr. Abato has been involved in all aspects of drug research from synthesis/purification, in-vitro, in-vivo (efficacy and pharmacokinetics) testing, dosing routs, drug formulation and the management of CROs to support pre-clinical testing.

He has also considerable experience with the testing of dietary supplements and rules governing dietary supplements. For example Dr Abato is familiar with the Code of Federal Regulations Title 21 (21 CFR), guidance for industry documents and the federal register of rules and regulations pertaining to 21 CFR.

Dr Abato has also opined in contract disputes relating to regulations from 21 CFR governing pharmaceutical supply chains, stability testing and manufacturing as they relate to the shelf life and of pharmaceutical products.

Paul Abato Recent Blog Posts

Featured Articles

The Paul Abato Consulting News Blog

by Paul | Aug 29, 2018 | Pharmaceutical Litigation News

I am excited to share some articles. Stay Tuned